Prostate Cancer - Results from #27800

High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A Phase II trial - Abstract June 1, 2011

Dealing with a troublesome body: A qualitative interview study of men's experiences living with prostate cancer treated with endocrine therapy - Abstract June 1, 2011

Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: A two-center chronologic cohort study - Abstract June 1, 2011

Editor's Commentary - Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: Improved outcomes with stringent enrollment criteria June 1, 2011

Hospital & Healthsystem Association of Pennsylvania (HAP) to host CUSP/CAUTI conference June 1, 2011

UroToday Slide Library - History of patupilone: From bench to clinic June 1, 2011

UroToday Slide Library - Hormone-refractory prostate cancer June 1, 2011

UroToday Slide Library - Prevention of prostate cancer: Is this the way to go? June 1, 2011

UroToday Slide Library - Ongoing trials and the future in hormone refractory prostate cancer June 1, 2011

UroToday Slide Library - Ablatherm® safety on long-term results June 1, 2011

UroToday Slide Library - Patupilone ovarian programme June 1, 2011

UroToday Slide Library - The increasing responsibility of the urologist in maintaining bone health in prostate cancer patients June 1, 2011

UroToday Slide Library - Ablatherm® long-term results as a salvage option after radiotherapy failure June 1, 2011

UroToday Slide Library - Patupilone future development programme June 1, 2011

UroToday Slide Library - Identifying the high risk patient: What is available? June 1, 2011

UroToday Slide Library - The Role Of Bisphosphonates In Metastatic Prostate Cancer June 1, 2011

UroToday Slide Library - Ablatherm® efficiency on long-term results June 1, 2011

UroToday Slide Library - mTOR: A new pathway to target in oncology June 1, 2011

UroToday Slide Library - PSA Nadir: A surrogate marker of long-term efficacy in HIFU therapy for localised prostate cancer June 1, 2011

UroToday Slide Library - The role of surgery in the high risk patient June 1, 2011

Page 1391 of 1435